Navigation Links
2010 Prix Galien USA Pro Bono Humanum Award to be Presented to UNITAID for Work In Global HIV/AIDS Effort
Date:9/9/2010

NEW YORK, Sept. 9 /PRNewswire/ -- The Prix Galien USA committee, responsible for awarding the most prestigious prize in biopharmaceutical research and development, today announced the 2010 winner of the Pro Bono Humanum Award for the 4th annual Prix Galien USA Awards competition. The award, recognizing exemplary and innovative efforts to improve the human condition, will be presented to UNITAID in partnership with the Clinton Health Access Initiative (CHAI) for their tremendous work combating the global HIV/AIDS epidemic.

Philippe Douste-Blazy, M.D., President of UNITAID, and President William J. Clinton, President of CHAI, will be accepting the award on behalf of their organizations. UNITAID and CHAI's efforts to reduce the price of quality medicines and diagnostics, while accelerating the pace at which these health products are made available, have resulted in the distribution of life-saving medicines to more than 456,000 people in 40 countries.

Elie Wiesel, Nobel Laureate and Prix Galien USA committee member, will present the award at a black tie ceremony at the American Museum of Natural History in New York City on September 28, 2010. The Prix Galien USA Pro Bono Humanum Award will accompany a series of other awards honoring companies who have made innovative contributions to biopharmaceutical and medical technology research and development.

"The collaboration between UNITAID and the Clinton Health Access Initiative truly embodies the spirit of the Pro Bono Award by moving us forward in improving the human condition, particularly for those affected by HIV/AIDS. The combination of innovative financing, philanthropic goals, and effective delivery of medicines makes this award and citation natural winners for the 2010 Pro Bono Award," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal. "Because of this partnership, three out of four children with AIDS are now being treated, and there has been a sharp reduction in the price of antiretroviral treatments for patients."

Each year, the Prix Galien USA committee awards a special Pro Bono Humanum Award to an individual, a company, an academic institution or a non-governmental agency that has helped to improve the human condition through the application of pharmaceutical science to problems of developing or underserved populations worldwide. Recent winners of the Pro Bono Humanum Award include: Dr. Roy Vagelos for his campaign to eradicate river blindness in 2007; Dr. Sheldon Segal and the Population Council in 2008 for their role in developing implantable hormone delivery systems and to Dr. Barry Bloom with Dr. Jeffrey Sachs in 2009 for their efforts with the Harvard School Public Health/Earth Institute to eradicate disease by understanding the immune responses to infectious diseases.

The Prix Galien recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines and devices such as these, and is considered the industry's highest accolade, equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA Award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about the Prix Galien USA Award and Committee, or to learn more about the Awards Gala, visit www.prix-galienusa.com.Contact: Lauren HamiltonLauren.Hamilton@edelman.com323-202-1425
'/>"/>

SOURCE Galien Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prix Galien USA Honors Innovation in Science and Biotech Industries
2. PainReliever.com Earns Inc. 5000 Award
3. Sysmex America Awarded National Novation GPO Contract for Automated Urinalysis
4. Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board
5. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
6. Invivo Wins Medical Design Excellence Award for Prostate Solutions
7. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
8. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
9. CRF Health is Awarded for Getting Closer
10. SRI International and Stanford University School of Medicines MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices
11. Zargis Awarded U.S. Army Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
Breaking Medicine Technology:
(Date:2/23/2017)... FL (PRWEB) , ... February 23, 2017 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – will return to the La Gorce Country Club in Miami Beach to ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss ... WE TV’s “Mama June: From Not to Hot,” which will begin airing on February ... Shannon, known to millions from the 2012 reality television series, “Here Comes Honey Boo ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO ... the National Institute for Health and Care Excellence (NICE) framework. The ... National Health Service (NHS) to search, order and purchase medical and healthcare-related content ...
(Date:2/23/2017)... ... 2017 , ... Pink Pig Publishing LLC announces the launch ... the world from different perspectives. By providing a place for people of all ... empathy, and find greater happiness. , "Our approach to structuring content is ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
Breaking Medicine News(10 mins):